Cencora Pre-Tax Profit Margin 2010-2025 | COR
Current and historical pre-tax profit margin for Cencora (COR) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Cencora pre-tax profit margin for the three months ending March 31, 2025 was .
| Cencora Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $310.23B | $2.30B | 0.74% |
| 2024-12-31 | $303.19B | $1.84B | 0.61% |
| 2024-09-30 | $293.96B | $2.00B | 0.68% |
| 2024-06-30 | $283.83B | $2.32B | 0.82% |
| 2024-03-31 | $276.54B | $2.31B | 0.83% |
| 2023-12-31 | $271.58B | $2.35B | 0.87% |
| 2023-09-30 | $262.17B | $2.16B | 0.82% |
| 2023-06-30 | $254.43B | $2.10B | 0.82% |
| 2023-03-31 | $247.54B | $1.96B | 0.79% |
| 2022-12-31 | $241.81B | $2.18B | 0.90% |
| 2022-09-30 | $238.59B | $2.18B | 0.91% |
| 2022-06-30 | $236.33B | $2.35B | 1.00% |
| 2022-03-31 | $229.67B | $2.45B | 1.07% |
| 2021-12-31 | $221.10B | $2.29B | 1.04% |
| 2021-09-30 | $213.99B | $2.22B | 1.04% |
| 2021-06-30 | $204.32B | $-4.47B | -2.19% |
| 2021-03-31 | $196.28B | $-4.70B | -2.40% |
| 2020-12-31 | $194.55B | $-5.00B | -2.57% |
| 2020-09-30 | $189.90B | $-5.29B | -2.79% |
| 2020-06-30 | $186.29B | $1.00B | 0.53% |
| 2020-03-31 | $186.16B | $1.02B | 0.55% |
| 2019-12-31 | $182.06B | $0.77B | 0.42% |
| 2019-09-30 | $179.59B | $0.97B | 0.54% |
| 2019-06-30 | $177.25B | $0.94B | 0.53% |
| 2019-03-31 | $175.15B | $0.91B | 0.52% |
| 2018-12-31 | $172.87B | $1.25B | 0.72% |
| 2018-09-30 | $167.94B | $1.18B | 0.70% |
| 2018-06-30 | $163.76B | $0.89B | 0.55% |
| 2018-03-31 | $159.33B | $0.68B | 0.43% |
| 2017-12-31 | $155.44B | $0.91B | 0.59% |
| 2017-09-30 | $153.14B | $0.92B | 0.60% |
| 2017-06-30 | $151.58B | $1.28B | 0.85% |
| 2017-03-31 | $149.76B | $1.64B | 1.10% |
| 2016-12-31 | $148.31B | $1.97B | 1.33% |
| 2016-09-30 | $146.85B | $1.39B | 0.95% |
| 2016-06-30 | $144.76B | $1.67B | 1.15% |
| 2016-03-31 | $142.11B | $1.48B | 1.04% |
| 2015-12-31 | $139.08B | $0.16B | 0.12% |
| 2015-09-30 | $135.96B | $0.27B | 0.20% |
| 2015-06-30 | $132.08B | $-0.02B | -0.01% |
| 2015-03-31 | $128.20B | $-0.26B | -0.21% |
| 2014-12-31 | $123.98B | $0.42B | 0.34% |
| 2014-09-30 | $119.57B | $0.67B | 0.56% |
| 2014-06-30 | $112.45B | $0.58B | 0.52% |
| 2014-03-31 | $104.01B | $0.64B | 0.61% |
| 2013-12-31 | $96.08B | $0.69B | 0.71% |
| 2013-09-30 | $87.96B | $0.83B | 0.94% |
| 2013-06-30 | $82.23B | $1.03B | 1.25% |
| 2013-03-31 | $79.65B | $1.22B | 1.53% |
| 2012-12-31 | $78.83B | $1.24B | 1.57% |
| 2012-09-30 | $78.08B | $1.22B | 1.56% |
| 2012-06-30 | $78.23B | $1.13B | 1.45% |
| 2012-03-31 | $79.07B | $1.13B | 1.42% |
| 2011-12-31 | $79.12B | $1.12B | 1.41% |
| 2011-09-30 | $78.70B | $1.12B | 1.42% |
| 2011-06-30 | $79.35B | $1.12B | 1.41% |
| 2011-03-31 | $78.79B | $1.08B | 1.38% |
| 2010-12-31 | $78.33B | $1.03B | 1.31% |
| 2010-09-30 | $77.78B | $1.02B | 1.31% |
| 2010-06-30 | $76.96B | $1.01B | 1.31% |
| 2010-03-31 | $75.75B | $0.94B | 1.25% |
| 2009-12-31 | $73.76B | $0.89B | 1.20% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.472B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.694B | 25.08 |
| Elevance Health (ELV) | United States | $90.401B | 11.66 |
| CVS Health (CVS) | United States | $78.570B | 9.77 |
| DiDi Global (DIDIY) | China | $22.450B | 34.07 |
| Natera (NTRA) | United States | $20.631B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.588B | 13.33 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.514B | 0.00 |
| CochLear (CHEOY) | Australia | $11.382B | 0.00 |
| Revvity (RVTY) | United States | $10.588B | 18.22 |
| ICON (ICLR) | Ireland | $10.225B | 9.51 |
| Viatris (VTRS) | United States | $9.953B | 3.42 |
| Doximity (DOCS) | United States | $9.475B | 44.13 |
| Avantor (AVTR) | United States | $8.552B | 12.43 |
| HealthEquity (HQY) | United States | $8.545B | 42.04 |
| Medpace Holdings (MEDP) | United States | $8.501B | 22.58 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.630B | 12.99 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.137B | 38.29 |
| Bausch + Lomb (BLCO) | Canada | $3.955B | 23.31 |
| Sotera Health (SHC) | United States | $3.503B | 19.90 |
| Alignment Healthcare (ALHC) | United States | $3.033B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.905B | 37.78 |
| Concentras Parent (CON) | United States | $2.803B | 16.20 |
| Organon (OGN) | United States | $2.191B | 2.33 |
| Ardent Health Partners (ARDT) | United States | $2.137B | 9.11 |
| GeneDx Holdings (WGS) | United States | $1.934B | 74.48 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.816B | 39.98 |
| PACS (PACS) | United States | $1.506B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Pediatrix Medical (MD) | United States | $1.303B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.037B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| CareDx (CDNA) | United States | $0.949B | 14.83 |
| Nutex Health (NUTX) | United States | $0.941B | 14.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.86 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 11.40 |
| LifeMD (LFMD) | United States | $0.489B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.360B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
| Oncology Institute (TOI) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (KDLY) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.131B | 21.33 |
| So-Young (SY) | China | $0.089B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |